Back to Search
Start Over
The Advisory Committee on Immunization Practices' Interim Recommendation for Use of Pfizer-BioNTech COVID-19 Vaccine -- United States, December 2020.
- Source :
-
MMWR: Morbidity & Mortality Weekly Report . 12/18/2020, Vol. 69 Issue 50, p1922-1924. 3p. - Publication Year :
- 2020
-
Abstract
- What is already known about this topic? On December 11, 2020, the Food and Drug Administration issued an Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine. What is added by this report? On December 12, 2020, after an explicit, evidence-based review of all available data, the Advisory Committee on Immunization Practices (ACIP) issued an interim recommendation for use of the Pfizer-BioNTech COVID-19 vaccine in persons aged =16 years for the prevention of COVID-19. What are the implications for public health practice? The recommendation for the Pfizer-BioNTech COVID-19 vaccine should be implemented in conjunction with ACIP's interim recommendation for allocating initial supplies of COVID-19 vaccines. [ABSTRACT FROM AUTHOR]
Details
- Language :
- English
- ISSN :
- 01492195
- Volume :
- 69
- Issue :
- 50
- Database :
- Academic Search Index
- Journal :
- MMWR: Morbidity & Mortality Weekly Report
- Publication Type :
- Academic Journal
- Accession number :
- 147695830
- Full Text :
- https://doi.org/10.15585/mmwr.mm6950e2